New PET scan tracer could spot breast cancer better
NCT ID NCT03863457
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study is testing a new radioactive tracer called [18F]F-GLN for PET/CT scans in people with breast cancer. The goal is to see how well this tracer highlights tumors and to gather safety information. Up to 40 adults with known or suspected breast cancer will receive one injection of the tracer and undergo imaging. The results will not be used to guide treatment decisions, but may help develop better ways to detect and understand breast cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
[18F]F-GLN (a radioactive tracer for PET/CT imaging)
What this could lead to
If successful, this could lead to a new imaging method to better detect and characterize breast cancer subtypes, potentially guiding more personalized treatment.
What could go wrong
This is a very early, small pilot study (40 people) focused on imaging, not treatment. The tracer may not provide clear or useful images, and results may not apply to all breast cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••